JP2015533817A5 - - Google Patents

Download PDF

Info

Publication number
JP2015533817A5
JP2015533817A5 JP2015533387A JP2015533387A JP2015533817A5 JP 2015533817 A5 JP2015533817 A5 JP 2015533817A5 JP 2015533387 A JP2015533387 A JP 2015533387A JP 2015533387 A JP2015533387 A JP 2015533387A JP 2015533817 A5 JP2015533817 A5 JP 2015533817A5
Authority
JP
Japan
Prior art keywords
peptide
protein
composition
target protein
domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015533387A
Other languages
English (en)
Japanese (ja)
Other versions
JP6550333B2 (ja
JP2015533817A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2013/050741 external-priority patent/WO2014047741A1/en
Publication of JP2015533817A publication Critical patent/JP2015533817A/ja
Publication of JP2015533817A5 publication Critical patent/JP2015533817A5/ja
Application granted granted Critical
Publication of JP6550333B2 publication Critical patent/JP6550333B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015533387A 2012-09-27 2013-09-27 ペプチドに誘導されたタンパク質ノックダウン Expired - Fee Related JP6550333B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261706506P 2012-09-27 2012-09-27
US61/706,506 2012-09-27
PCT/CA2013/050741 WO2014047741A1 (en) 2012-09-27 2013-09-27 Peptide directed protein knockdown

Publications (3)

Publication Number Publication Date
JP2015533817A JP2015533817A (ja) 2015-11-26
JP2015533817A5 true JP2015533817A5 (https=) 2016-11-04
JP6550333B2 JP6550333B2 (ja) 2019-07-24

Family

ID=50386747

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015533387A Expired - Fee Related JP6550333B2 (ja) 2012-09-27 2013-09-27 ペプチドに誘導されたタンパク質ノックダウン

Country Status (7)

Country Link
US (3) US10287333B2 (https=)
EP (1) EP2900697B1 (https=)
JP (1) JP6550333B2 (https=)
CN (2) CN104797603B (https=)
AU (1) AU2013323101C1 (https=)
CA (1) CA2885894C (https=)
WO (1) WO2014047741A1 (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108779167A (zh) * 2015-10-28 2018-11-09 宾夕法尼亚州大学信托人 鞘内施用腺伴随病毒载体用于基因治疗
WO2017079723A1 (en) * 2015-11-07 2017-05-11 Board Of Regents, The University Of Texas System Targeting proteins for degradation
CN116082457A (zh) 2016-02-01 2023-05-09 堪培拉大学 蛋白化合物及其用途
EA037848B1 (ru) * 2016-07-14 2021-05-27 Общество С Ограниченной Ответственностью "Биохимический Агент" Гибридный белок, полинуклеотид, генетическая конструкция, продуцент, препарат для регенерации хряща (варианты)
WO2018103038A1 (zh) * 2016-12-08 2018-06-14 拜西欧斯(北京)生物技术有限公司 一种缀合物及其应用
US10906949B2 (en) * 2017-06-28 2021-02-02 The Cleveland Clinic Foundation Methods of treating spinal cord injury using a chondroitin sulfate proteoglycan (CSPG) reduction peptide (CRP) comprising a cell membrane penetrating domain, a CSPG binding domain, and a lysosome targeting domain
CN109553685B (zh) * 2017-09-25 2021-07-27 华中科技大学 一种小分子多肽及其在制备防治缺血性脑卒中药物中的应用
WO2019090390A1 (en) 2017-11-08 2019-05-16 University Of Canberra Immunogenic compositions and uses therefor
CN108358999A (zh) * 2018-01-17 2018-08-03 南京师范大学 一种雌激素受体靶向肽及其制备和应用
CN112654702B (zh) * 2018-09-07 2025-05-13 阿斯利康(瑞典)有限公司 改进的核酸酶的组合物和方法
CN111363014A (zh) * 2018-12-26 2020-07-03 苏州格兰科医药科技有限公司 用于治疗创伤性脑损伤的多肽及其用途和制备方法
US20220170930A1 (en) * 2019-03-11 2022-06-02 Fudan University Method for screening compound for treating or preventing polyq-related neurodegenerative diseases
CN110013542B (zh) * 2019-03-20 2022-09-20 南通大学 一种预防/治疗突触核蛋白病的药物及多肽类似物
WO2021223026A1 (en) * 2020-05-06 2021-11-11 University Of British Columbia Ezh1/2 knockdown peptides, methods and uses thereof
CN112142856B (zh) * 2020-09-30 2022-05-03 中国人民解放军空军军医大学 一种用于改善脑卒中兴奋性毒性损伤的特异性降解ndrg2靶向肽及其应用
US20260027179A1 (en) * 2021-02-08 2026-01-29 University Of British Columbia Anti-synucleinopathy peptide and methods to treat neurodegenerative diseases
CN115215939B (zh) * 2021-04-14 2025-09-23 中山大学 一种融合蛋白及其制备方法与应用
CN116102657A (zh) * 2021-11-09 2023-05-12 四川大学华西医院 一种基于多肽Pep42构建的嵌合抗原受体免疫细胞制备及其应用
WO2024044493A2 (en) * 2022-08-22 2024-02-29 The Johns Hopkins University Treatment of repeat expansion disease
CN115957348A (zh) * 2023-02-23 2023-04-14 澳门科技大学 靶向类风湿性关节炎脂质体递药系统、制备方法及应用
CN116590342B (zh) * 2023-05-11 2026-04-03 普递瑞(上海)医药有限公司 一种aav载体及其应用
WO2024229777A1 (zh) * 2023-05-11 2024-11-14 深圳先进技术研究院 一种aav载体及其应用
WO2025113706A1 (zh) * 2023-12-01 2025-06-05 苏州格兰科医药科技有限公司 一种化学修饰的多肽
WO2025113713A1 (zh) * 2023-12-01 2025-06-05 苏州格兰科医药科技有限公司 用于治疗新生儿缺氧缺血性脑病的组合物和方法
CN119638819B (zh) * 2024-12-04 2025-12-30 厦门大学 一种靶向降解tmem59多肽及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6225444B1 (en) 1998-02-10 2001-05-01 Protarga, Inc. Neuroprotective peptides and uses thereof
US7510824B2 (en) * 1999-06-02 2009-03-31 Nono Inc. Method of screening peptides useful in treating traumatic injury to the brain or spinal cord
WO2001047496A1 (en) * 1999-12-29 2001-07-05 Mixson A James Histidine copolymer and methods for using same
US6632616B2 (en) 2000-03-16 2003-10-14 Duke University Compounds that selectively bind to expanded polyglutamine repeat domains and methods of use thereof
JP2003009883A (ja) * 2001-07-05 2003-01-14 Mitsubishi Pharma Corp マスト細胞の細胞死誘発剤
AU2002365396A1 (en) * 2001-11-21 2003-06-10 The Trustees Of The University Of Pennsylvania Peptides, peptide compositions,and methods of use in binding p 185
US7740839B2 (en) * 2003-10-31 2010-06-22 Tae-Yoon Kim EC SOD and cell transducing EC SOD and use thereof
US20060014712A1 (en) * 2004-05-30 2006-01-19 Cemines, Inc. Controlled delivery of therapeutic compounds
CN101374860A (zh) * 2005-12-23 2009-02-25 技术转让合伙人公司 用作神经递质分泌抑制剂和肌肉松弛诱导物的合成肽
US20070244057A1 (en) 2006-01-20 2007-10-18 Henry Paulson Suppressing polyglutamine aggregation and toxicity
US7744879B2 (en) 2006-06-07 2010-06-29 Wisconsin Alumni Research Foundation Blood-brain barrier targeting antibodies
CN101008012A (zh) * 2006-10-27 2007-08-01 王尚武 一种新型人源神经营养因子bdnf表达结构及其表达
CN101134780A (zh) * 2007-07-09 2008-03-05 南京医科大学 阻断nr2b信号通路的多肽类似物及其制备方法和药物用途
US20100016221A1 (en) 2008-07-17 2010-01-21 Riken Method of degrading protein by chaperone-mediated autophagy
HRP20160385T1 (hr) * 2009-03-09 2016-05-06 Ramot At Tel-Aviv University Ltd. Pripravci za prevenciju i liječenje neurodegenerativnih bolesti
US9746475B2 (en) * 2011-03-14 2017-08-29 University Of Southern California Antibody and antibody mimetic for visualization and ablation of endogenous proteins
US20130065267A1 (en) * 2011-09-09 2013-03-14 Emory University Conjugates and methods for measuring chaperone-mediated autophagy

Similar Documents

Publication Publication Date Title
JP2015533817A5 (https=)
CN104507961B (zh) 抗炎性肽及包含其的组合物
Bechara et al. Cell-penetrating peptides: 20 years later, where do we stand?
Rai Peptide and protein mimetics by retro and retroinverso analogs
NO342964B1 (no) Blandinger som kan fremme sårheling
EP2297182A2 (en) Supercharged proteins for cell penetration
WO2013080147A3 (en) Anticancer fusion protein
Kanchi et al. Polyproline chains destabilize the Alzheimer’s amyloid-β protofibrils: A molecular dynamics simulation study
CA3040645A1 (en) Peptide-based non-proteinaceous cargo delivery
Duong et al. Cell-permeable parkin proteins suppress Parkinson disease-associated phenotypes in cultured cells and animals
JP2014530607A5 (https=)
US20220356226A1 (en) Compounds and methods for the treatment of alzheimer's disease
WO2012142245A3 (en) Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use
Li et al. Correlation between hydrophobic properties and efficiency of carrier-mediated membrane transduction and apoptosis of a p53 C-terminal peptide
US20210403526A1 (en) Tmem100 peptides and variants thereof and their use in treating or preventing diseases or conditions
CN111601815A (zh) 靶向细胞中c-Myc的嵌合分子
Hou et al. Feleucin‐BO 1: a novel antimicrobial non‐apeptide amide from the skin secretion of the toad, Bombina orientalis, and design of a potent broad‐spectrum synthetic analogue, feleucin‐K 3
US10993983B2 (en) Cyclic peptide epitopes and small-molecule mimics for inducing autophagy
EP2970510A1 (en) Methods and compositions for treating cancer and inflammatory diseases
Lee et al. Regulatory networks of the retinoblastoma protein
RS66946B1 (sr) Peptidna jedinjenja i njihove terapijske upotrebe
KR20090109932A (ko) 글리코겐 합성효소 키나이제 베타 억제제
Xin et al. Kalirin12 interacts with dynamin
JP7726464B2 (ja) Big3-phb2相互作用阻害phb2由来ペプチドを含む乳がん治療薬
Lv et al. Hematopoietic Cell Kinase Promotes Cerebral Ischemic Injury and Mitochondrial Dysfunction via p38 Activation in Ischemic Stroke